DM0000: The mark consists of the stylized wording "RHYTHM PHARMACEUTICALS PIONEERING A PATH FORWARD" wherein a portion of the vertical stem of the capital "R" in "RHYTHM" is formed by a dot.
GS0051: Pharmaceuticals and medicines for the treatment of metabolic diseases and disorders, namely, obesity
CC0000: Color is not claimed as a feature of the mark.
DS0000: PHARMACEUTICALS
GS0421: Research and product development services in the fields of metabolic diseases and disorders, namely, obesity
Case File Event Statements
9/28/2023 - a year ago
1 - NEW APPLICATION ENTEREDType:NWAP
10/11/2023 - a year ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
10/12/2023 - a year ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSC